Reticulocalbin 2 as a Potential Biomarker and Therapeutic Target for Atherosclerosis is a research paper published in Cells (2022). On theSindex it has a DataRank of 0. It has been cited 12 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: DK116768
NIDDK NIH HHS
Grant: R01 DK116768
National Institutes of Health
Grant: 5R01DK116768-04
Genetic connections between type 2 diabetes and atherosclerosis
National Institutes of Health
Grant: 1R21HL112281-01
H2 haplotype and atherosclerosis
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals